Valerie Oberhardt
Freiburg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Fate of hepatitis D virus-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta☆.
Journal: JHEP reports : innovation in hepatology
Published: January 05, 2026
Diverse cytomegalovirus US11 antagonism and MHC-A evasion strategies reveal a tit-for-tat coevolutionary arms race in hominids.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 20, 2024
A 3-Year Course Of Bulevirtide Monotherapy May Cure Hdv Infection In Cirrhotics.
Journal: Journal of hepatology
Published: October 28, 2022
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients.
Journal: Journal of hepatology
Published: October 25, 2022
COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation.
Journal: Nature communications
Published: June 01, 2022
SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals.
Journal: Nature microbiology
Published: January 17, 2022
Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.
Journal: Viruses
Published: December 07, 2021
Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine.
Journal: Nature
Published: May 07, 2021
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells.
Journal: Nature medicine
Published: September 04, 2020
Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells.
Journal: Journal of virology
Published: November 01, 2017
Last Updated: 09/26/2026